Macular hole surgery without using adjunctive additives

Ophthalmic Surgery and Lasers

Volumn 28, Issue 9, 1997, Pages 713-717

  Smiddy, William E ^a,c   Pimentel, Sergio ^b   Williams, George A ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA HOLE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSTURE; PROSPECTIVE STUDIES; RETINAL PERFORATIONS; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 0030882189     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol. 1991;109:654-659.
2. 2 for the treatment of full-thickness macular holes: a prospective randomized study. Ophthalmology. 1992;99: 1162-1173.
3. 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes. Retina. 1993;13:296-301.
4. Lansing MB, Glaser BM, Liss H, et al. The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes. Ophthalmology. 1993;100: 868-872.
5. Wendel RT, Patel AC, Kelly NE, Salzano TC, Wells JW, Novack GD. Vitreous surgery for macular holes. Ophthalmology. 1993;100:1671-1676.
6. Ryan EH, Gilbert HD. Results of surgical treatment of recent-onset full-thickness idiopathic macular holes. Arch Ophthalmol. 1994;112:1545-1553.
7. Ruby AJ, Williams DF, Grand MG, et al. Pars plana vitrectomy for treatment of stage 2 macular holes. Arch Ophthalmol. 1994;112:359-364.
8. Poliner LS, Tornambe PK. Retinal pigment epitheliopathy after macular hole surgery. Ophthalmology. 1992;99:1671-1677.
9. Sjaarda RN, Glaser BM, Thompson JT, Murphy RP. Pars plana vitrectomy, fluid-gas exchange and instillation of TGF-beta in eyes with idiopathic macular holes and vision better than 20/80. Retina Society Abstracts. 1993:54.
10. Liggett PE, Skolik SA, Horio B, Saito Y, Alfaro V, Meiler W. Human autologous serum for the treatment of full-thickness macular holes. Ophthalmology. 1995; 102:1071-1076.
11. Gaudric A, Massin P, Paques M, et al. Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol. 1995;233:549-554.
12. Johnson MW, Vine AK. Thrombin in the management of full-thickness macular holes. Retina. 1996;16: 474-478.
13. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP, Hanham A. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology. 1994;101:1195-1200.
14. Early Treatment Diabetic Retinopathy Study (ETDRS). Manual of Operations. Bethesda, MD: National Technical Information Service; 1985. Accession No. PB85 223006.
15. Thompson JT, Smiddy WE, Williams G, Sjaarda RN, Flynn HW, Glaser BM. Recombinant TGF-beta versus placebo for macular hole surgery. Submitted for publication.
16. Fine SL. Vitreous surgery for macular hole in perspective: is there an indication? Arch Ophthalmol. 1991; 109:635-636. Editorial.
17. Polk T, Smiddy WE, Flynn HW Jr. Bilateral visual function following macular hole surgery. Ophthalmology. 1996;103:422-426.